Putnam Focused Large Cap Growth ETF (PGRO) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free PGRO Stock Alerts $31.06 -0.19 (-0.61%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Putnam Focused Large Cap Growth ETF Stock Price Performance5 Day Performance+1.82%1 Month Performance-5.48%3 Month Performance+2.55%6 Month Performance+25.11%Year-To-Date Performance+7.22%1 Year Performance+37.62% Receive PGRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Putnam Focused Large Cap Growth ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... PGRO Stock Chart for Thursday, April, 25, 2024 PGRO Chart by TradingView Putnam Focused Large Cap Growth ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$31.27$31.25-0.05%$31.42$31.185,441 shs$57.19 million04/23/2024$30.77$31.27+1.63%$31.33$31.238,231 shs$57.22 million04/22/2024$30.51$30.77+0.85%$30.98$30.5910,889 shs$56.30 million04/19/2024$31.30$30.51-2.52%$31.01$30.4118,818 shs$55.83 million04/18/2024$31.47$31.30-0.55%$31.62$31.2124,842 shs$57.28 million04/17/2024$31.83$31.47-1.12%$31.84$31.475,091 shs$57.60 million Get the Latest News and Ratings for PGRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Putnam Focused Large Cap Growth ETF and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$31.79$31.83+0.12%$31.95$31.773,792 shs$58.25 million04/15/2024$32.36$31.79-1.75%$32.58$31.797,483 shs$58.18 million04/12/2024$32.83$32.36-1.42%$32.58$32.287,026 shs$59.22 million04/11/2024$32.33$32.83+1.54%$32.84$32.326,393 shs$60.07 million04/10/2024$32.44$32.33-0.34%$32.33$32.208,354 shs$41.06 million04/09/2024$32.48$32.44-0.12%$32.67$32.30953 shs$41.20 million04/08/2024$32.55$32.48-0.20%$32.51$32.48709 shs$41.25 million04/05/2024$32.05$32.55+1.56%$32.66$32.181,918 shs$41.34 million04/04/2024$32.52$32.05-1.45%$32.84$32.052,060 shs$40.70 million04/03/2024$32.39$32.52+0.40%$32.67$32.2939,413 shs$41.30 million04/02/2024$32.64$32.39-0.77%$32.39$32.184,124 shs$41.14 million04/01/2024$32.70$32.64-0.18%$32.74$32.5810,851 shs$41.45 million03/29/2024$32.70$32.70$32.80$32.6518,218 shs$41.53 million03/28/2024$32.72$32.70-0.05%$32.80$32.6518,218 shs$41.53 million03/27/2024$32.77$32.72-0.17%$32.95$32.604,616 shs$41.55 million03/26/2024$32.86$32.77-0.27%$33.03$32.7714,917 shs$41.62 million03/25/2024$33.05$32.86-0.57%$32.99$32.865,894 shs$41.73 million03/22/2024$33.06$33.05-0.03%$33.11$32.9421,459 shs$41.97 million03/21/2024$32.92$33.06+0.43%$33.23$33.053,859 shs$41.99 million03/20/2024$32.58$32.92+1.04%$32.92$32.567,626 shs$41.81 million03/19/2024$32.36$32.58+0.68%$32.58$32.311,114 shs$41.38 million03/18/2024$32.07$32.36+0.91%$32.58$32.362,692 shs$41.10 million03/15/2024$32.38$32.06-0.99%$32.21$32.063,986 shs$40.72 million03/14/2024$32.35$32.38+0.09%$32.57$32.342,991 shs$41.12 million03/13/2024$32.52$32.35-0.52%$32.50$32.345,303 shs$41.08 million03/12/2024$31.84$32.52+2.14%$32.52$32.261,931 shs$41.30 million03/11/2024$32.09$31.84-0.77%$31.91$31.8421,189 shs$40.44 million03/08/2024$32.53$32.09-1.35%$32.09$32.0998 shs$40.75 million03/07/2024$32.05$32.53+1.49%$32.59$32.481,674 shs$41.31 million03/06/2024$31.88$32.05+0.53%$32.23$32.054,616 shs$40.70 million03/05/2024$32.49$31.88-1.88%$32.32$31.754,293 shs$40.49 million03/04/2024$32.54$32.49-0.17%$32.64$32.496,324 shs$41.26 million03/01/2024$32.16$32.53+1.16%$32.54$32.2910,662 shs$41.31 million02/29/2024$31.81$32.16+1.09%$32.16$31.95157,130 shs$40.84 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024$31.92$31.81-0.34%$31.81$31.695,048 shs$40.40 million02/27/2024$31.92$31.920.00%$31.99$31.807,394 shs$40.54 million02/26/2024$31.98$31.92-0.19%$32.06$31.925,935 shs$40.54 million02/23/2024$31.94$31.98+0.13%$32.23$31.963,715 shs$40.62 million02/22/2024$30.75$31.94+3.87%$31.94$31.814,139 shs$40.56 million02/21/2024$31.04$30.75-0.93%$30.83$30.686,119 shs$39.05 million02/20/2024$31.45$31.04-1.30%$31.09$30.942,122 shs$39.42 million02/19/2024$31.45$31.450.00%$31.70$31.452,100 shs$39.94 million02/16/2024$31.67$31.45-0.69%$31.70$31.452,129 shs$39.94 million02/15/2024$31.72$31.67-0.16%$31.67$31.498,735 shs$40.22 million02/14/2024$31.26$31.72+1.47%$31.72$31.524,457 shs$40.28 million02/13/2024$31.66$31.26-1.26%$31.43$31.097,356 shs$39.70 million02/12/2024$31.90$31.66-0.75%$31.97$31.629,357 shs$40.21 million02/09/2024$31.60$31.90+0.95%$31.96$31.8111,661 shs$40.51 million02/08/2024$31.59$31.60+0.03%$31.64$31.606,329 shs$40.13 million02/07/2024$31.05$31.59+1.74%$31.59$31.245,394 shs$40.12 million02/06/2024$31.05$31.05+0.00%$31.05$30.922,761 shs$39.43 million02/05/2024$31.08$31.05-0.10%$31.09$31.05625 shs$39.43 million02/02/2024$30.36$31.08+2.37%$31.08$30.733,512 shs$39.47 million02/01/2024$29.94$30.36+1.40%$30.39$30.1710,662 shs$38.56 million01/31/2024$30.56$29.94-2.03%$30.20$29.943,477 shs$38.02 million01/30/2024$30.66$30.56-0.33%$30.64$30.566,812 shs$38.81 million01/29/2024$30.25$30.66+1.36%$30.66$30.3619,536 shs$38.94 million01/26/2024$30.29$30.25-0.12%$30.37$30.2215,060 shs$38.42 million01/25/2024$30.33$30.29-0.14%$30.46$30.16156,897 shs$38.47 million01/24/2024$30.22$30.33+0.36%$30.59$30.3312,152 shs$38.52 million Related Companies: SPXN Stock Price Chart AZBJ Stock Price Chart BSTP Stock Price Chart AZBA Stock Price Chart ADPV Stock Price Chart SPXT Stock Price Chart QARP Stock Price Chart HIBL Stock Price Chart SPYC Stock Price Chart DECT Stock Price Chart Receive PGRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Putnam Focused Large Cap Growth ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PGRO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam Focused Large Cap Growth ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.